Antioxidant therapy for preserving and restoring male reproductive health

Igor A. Korneyev

For citation:

Abstract

The article is devoted to a review of modern concepts of maintaining men's reproductive health, the role oxidative stress plays in pathogenesis of male infertility and efficacy of antioxidant therapy with the supplements containing β-carotene, vitamins E and C, as well as micronutrients selenium and zinc in reproductive dysfunction prevention and treatment with the focus on Selzinc Plus efficacy and safety.

Key words: male infertility, men’s health, oxidative stress, antioxidants, selenium, zinc, vitamin E, vitamin C, beta-carotine.

References

1. Данные с сайта ТАСС (tass.ru). URL: https://tass.ru/obschestvo/ 23514297 Data from the TASS website (tass.ru ). URL: https://tass.ru/obschestvo/23514297 (in Russian).

2. Лебедев Г.С., Голубев Н.А., Шадеркин И.А. и др. Мужское бесплодие в Российской Федерации: статистические данные за 2000–2018 гг. Экспериментальная и клиническая урология. 2019;(4): 4-13. Lebedev G.S., Golubev N.A., Shaderkin I.A. et al. Male infertility in the Russian Federation: statistical data for 2000–2018. Experimental and clinical urology. 2019;(4):4-13 (in Russian).

3. Infertility prevalence estimates, 1990–2021. Geneva: World Health Organization, 2023. Licence: CC BY-NC-SA 3.0 IGO.

4. Levine H, Jørgensen N, Martino-Andrade A et al. Temporal trends in sperm count: a systematic review and meta-regression analysis of samples collected globally in the 20th and 21st centuries. Hum Reprod Update. 2022;Nov 15:dmac035.

5. Корнеев И.А. Сравнительная характеристика параметров эякулята мужчин, обратившихся в центр репродуктивной медицины с 2016 по 2022 г. Урологические ведомости. 2023;13(1):23-29. Korneev I.A. Comparative characteristics of the ejaculate parameters of men who applied to the Center for Reproductive Medicine from 2016 to 2022. Urological reports. 2023;13(1):23-29 (in Russian).

6. Регистр вспомогательных репродуктивных технологий. Отчет за 2022 г. Российская ассоциация репродукции человека. URL: https://www.rahr.ru/d_registr_otchet/RegistrVRT_2022.pdf Registry of Assisted Reproductive Technologies. Report for 2022 by the Russian Association of Human Reproduction. URL: https://www. rahr.ru/d_registr_otchet/RegistrVRT_2022.pdf (in Russian).

7. Епанчинцева Е.А., Селятицкая В.Г., Свиридова М.А., Лутов Ю.В. Медико-социальные факторы риска бесплодия у мужчин. Андрология и генитальная хирургия. 2016;(3):47-53. Epanchintseva E.A., Selyatitskaya V.G., Sviridova M.A., Lutov Yu.V. Medical and social risk factors for infertility in men. Andrology and genital surgery. 2016;(3):47-53 (in Russian).

8. Носова Г.Г., Федорцова Ю.В., Морев В.В., Корнеев И.А. Изучение факторов риска развития бесплодия у мужчин, обратившихся в центр вспомогательных репродуктивных технологий. Урологические ведомости. 2013;3(3):18-21. Nosova G.G., Fedorova Yu.V., Morev V.V., Korneev I.A. Study of risk factors for infertility in men who applied to the center for assisted reproductive technologies. Urological reports. 2013;3(3):18-21 (in Russian).

9. Agarwal A, Parekh N, Panner Selvam MK et al. Male Oxidative Stress Infertility (MOSI): Proposed Terminology and Clinical Practice Guidelines for Management of Idiopathic Male Infertility. World J Mens Health 2019;37(3):296-312.

10. De Lamirande E, Jiang H, Zini A et al. Reactive oxygen species and sperm physiology. Rev Reprod 1997;(2):48-54.

11. Colaco S, Sakkas D. Paternal factors contributing to embryo quality. J Assist Reprod Genet 2018;35(11):1953-68.

12. Klimczak AM, Patel DP, Hotaling JM, Scott RT Jr. Role of the sperm, oocyte, and embryo in recurrent pregnancy loss. Fertility and sterility 2021;115(3):533-7.

13. Aitken RJ. DNA damage in human spermatozoa; important contributor to mutagenesis in the offspring. Transl Androl Urol 2017;6(Suppl 4):S761-S764.

14. Fallara G, Pozzi E, Belladelli F et al. A Systematic Review and Meta-analysis on the Impact of Infertility on Men's General Health. Eur Urol Focus 2024;10(1):98-106.

15. Мужское бесплодие. Клинические рекомендации. Российское общество урологов. М., 2025. URL: https://cr.minzdrav.gov.ru/preview-cr/5_3 Male infertility. Clinical recommendations. Russian Society of Urologists. Moscow, 2025. URL: https://cr.minzdrav.gov.ru/preview-cr/5_3 (in Russian).

16. Данные с сайта Ведомости (vedomosti.ru). URL: https://www.vedomosti.ru/society/articles/2025/02/19/1093003-za-2024-g-dispanserizatsiyu-proshlo-bolee-82-mln-vzroslih Data from the Vedomosti website (vedomosti.ru). URL: https://www. vedomosti.ru/society/articles/2025/02/19/1093003-za-2024-g-dispanserizatsiyu-proshlo-bolee-82-mln-vzroslih (in Russian).

17. Заседание Совета по региональному здравоохранению при СФ – 19 февраля 2025 года. URL: https://vmeste-rf.tv/broadcast/zasedanie-soveta-po-regionalnomu-zdravookhraneniyu-pri-sf-19-fevralya-2025-goda-/?sphrase_id=495122 The meeting of the Council on Regional Healthcare under the Federation Council will be held on February 19, 2025. URL: https://vmeste-rf.tv/broadcast/zasedanie-soveta-po-regionalnomu-zdravookhraneniyu-pri-sf-19-fevralya-2025-goda-/?sphrase_id=495122 (in Russian).

18. Корнеев И.А. Мужское бесплодие при оксидативном стрессе: пути решения проблемы. Урология. 2022;(1):40-6. Korneev I.A. Male infertility under oxidative stress: ways to solve the problem. Urology. 2022;(1):40-6 (in Russian).

19. Ener K, Aldemir M, Isik E et al. The impact of vitamin E supplementation on semen parameters and pregnancy rates after varicocelectomy: A randomised controlled study. Andrologia 2016;(48):829- 34.

20. Kodama H, Yamaguchi R, Fukuda J et al. Increased oxidative deoxyribonucleic acid damage in the spermatozoa of infertile male patients. Fertil Steril 1997;68:519-24.

21. Vezina D, Mauffette F, Roberts KD, Bleau G. Selenium-vitamin E supplementation in infertile men. Effects on semen parameters and micronutrient levels and distribution. Biol Trace Elem Res 1996;(53):65-83. 22. Kessopoulou E, Powers HJ, Sharma KK et al. A double-blind randomized placebo cross-over controlled trial using the antioxidant vitamin E to treat reactive oxygen species associated male infertility. Fertil Steril 1995;(64):825-31.

23. Moslemi MK, Tavanbakhsh S. Selenium-vitamin E supplementation in infertile men: Effects on semen parameters and pregnancy rate. Int J Gen Med 2011;(4):99-104.

24. Geva E, Bartoov B, Zabludovsky N et al. The effect of antioxidant treatment on human spermatozoa and fertilization rate in an in vitro fertilization program. Fertil Steril 1996;66(3):430-4.

25. Song GJ, Norkus EP, Lewis V. Relationship between seminal ascorbic acid and sperm DNA integrity in infertile men. Int J Androl 2006;29(6):569-75.

26. Iqbal K, Khan A, Khattak M. Biological significance of ascorbic acid (vitamin C) in human health-a review. Pak J Nutr 2004;(3):5-13.

27. Mangoli E, Talebi AR, Anvari M et al. Vitamin C attenuates negative effects of vitrification on sperm parameters, chromatin quality, apoptosis and acrosome reaction in neat and prepared normozoospermic samples. Taiwan J Obstet Gynecol 2018;(57):200-4.

28. Eskenazi B, Kidd SA, Marks AR et al. Antioxidant intake is associated with semen quality in healthy men. Hum Reprod 2005;20(4):1006-12.

29. Calogero AE, Condorelli RA, Russo GI, La Vignera S. Conservative Nonhormonal Options for the Treatment of Male Infertility: Antibiotics, Anti-Inflammatory Drugs, and Antioxidants. Biomed Res Int 2017;2017:4650182.

30. Qazi IH, Angel C, Yang H et al. Role of Selenium and Selenoproteins in Male Reproductive Function: A Review of Past and Present Evidences. Antioxidants 2019;(8):268.

31. Zhang Y, Roh YJ, Han SJ et al. Role of Selenoproteins in Redox Regulation of Signaling and the Antioxidant System. A Review Antioxidants 2020;(9):383.

32. Oldereid NB, Thomassen Y, Purvis K. Selenium in human male reproductive organs. Hum Reprod 1998;(13):2172-6.

33. Bedwal RS, Bahuguna A. Zinc, copper and selenium in reproduction. Experientia 1994;(50):626-40.

34. Zhao J, Dong X, Hu X et al. Zinc levels in seminal plasma and their correlation with male infertility: A systematic review and meta-analysis. Sci Rep 2016;(6):22386.

35. Hadwan MH, Almashhedy LA, Alsalman AR. Study of the effects of oral zinc supplementation on peroxynitrite levels, arginase activity and NO synthase activity in seminal plasma of Iraqi asthenospermic patients. Reprod Biol Endocrinol 2014;(12):1.

36. Fallah A, Mohammad-Hasani A, Colagar AH. Zinc is an essential element for male fertility: A review of Zn roles in men’s health, germination, sperm quality, and fertilization. J Reprod Infertil 2018;(19):69-81.

37. de Ligny W, Smits RM, Mackenzie-Proctor R et al. Antioxidants for male subfertility. Cochrane Database Syst Rev 2022;5(5):CD007411.

38. Dimitriadis F, Borgmann H, Struck JP et al. Antioxidant Supplementation on Male Fertility-A Systematic Review. Antioxidants (Basel) 2023;12(4):836.

39. Сивков А.В., Ощепков В.Н., Евдокимов В.В. и др. Эффективность и безопасность препарата Селцинк плюс у пациентов с хроническим неинфекционным простатитом и нарушениями фертильности. Consilium Medicum. 2011;13(7):5-9. Sivkov A.V., Oshchepkov V.N., Evdokimov V.V. et al. Efficacy and safety of Selzink plus in patients with chronic non-communicable prostatitis and fertility disorders. Consilium Medicum. 2011;13(7):5-9 (in Russian).

40. Неймарк А.И., Клепикова И.И. Применение препарата Селцинк плюс у мужчин с нарушением фертильности. Андрология и генитальная хирургия. 2013;(4):77-80. Neymark A.I., Klepikova I.I. The use of Selzink plus in men with impaired fertility. Andrology and genital surgery. 2013;(4):77-80 (in Russian).

41. Кульчавеня Е.В., Осадчий АВ. Эффективность сперматопротективной терапии на основе Селцинка плюс у больных туберкулезом предстательной железы. Consilium Medicum. 2016;18(7):22-6. Kulchavenya E.V., Osadchy A. V. The effectiveness of spermatoprotective therapy based on Selcink plus in patients with tuberculosis of the prostate gland. Consilium Medicum. 2016;18(7):22-6 (in Russian).

For citation: Korneyev I.A. Antioxidant therapy for preserving and restoring male reproductive health. Clinical review for general practice. 2025; 6 (6) 101–106 (In Russ.). DOI: 10.47407/kr2025.6.6.00637

All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

Clinical review for general practice